%0 Figure %A van Scheppingen, J. %A Broekaart, D. %A Scholl, T. %A Zuidberg, M. %A Anink, J. %A Spliet, W. %A van Rijen, P. %A Czech, T. %A Hainfellner, J. %A Feucht, M. %A Mühlebner, A. %A van Vliet, E. %A Aronica, E. %D 2016 %T Additional file 3: Figure S3. of Dysregulation of the (immuno)proteasome pathway in malformations of cortical development %U https://springernature.figshare.com/articles/figure/Additional_file_3_Figure_S3_of_Dysregulation_of_the_immuno_proteasome_pathway_in_malformations_of_cortical_development/4326131 %R 10.6084/m9.figshare.c.3598799_D2.v1 %2 https://springernature.figshare.com/ndownloader/files/7049651 %K Immunoproteasome %K Inflammation %K Immunohistochemistry %K Tuberous sclerosis complex %K Focal cortical dysplasia %K Epilepsy %K Astrocytes %X Effect of the different treatments on fetal astrocyte cell cultures. A: scatterplots of eFluor viability dye staining as analyzed by flow cytometry after different treatments. B: Quantification of viable cells based on eFluor viability staining. Neither treatment with IL-1β nor rapamycin negatively influenced viability of cell cultures. C: Western blot analysis showed effective reduction of phosphorylated S6 after 24 h of 100 nM rapamycin treatment. FSC: forward scatter. (JPG 1420 kb) %I figshare